Axel Bolte

Biography

Axel Bolte currently serves as an investment advisor to HBM Partners AG, based in Zug, Switzerland. He has 16 years of experience in health care venture capital.  Mr. Bolte was an investment manager at New Medical Technologies (NMT) AG, the first Swiss healthcare-focused venture capital firm.  Since joining the private equity team at HBM Partners in 2003, he has led multiple biopharma investments. Previously, Mr. Bolte held a position in R&D management at Serono SA, Geneva. He currently serves or has served on the board of directors of various private and public biotechnology companies, including Adnexus Therapeutics (acquired by BMS), Kolltan Pharmaceuticals, Newron Pharmaceuticals (SWX: NWRN), PTC Therapeutics (NASDAQ:PTCT) and Ophthotech (NASDAQ: OPHT). 

Research Interest

 Healthcare